Johnson & Johnson
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
Access to medicines: Governments must scale up better TB treatment as J&J drops crucial drug price
Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug
Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India